Connection

Martin Bachmann to Melanoma

This is a "connection" page, showing publications Martin Bachmann has written about Melanoma.
Connection Strength

0.349
  1. Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine. Front Immunol. 2019; 10:1015.
    View in: PubMed
    Score: 0.349
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.